Patents by Inventor Gregory Grover
Gregory Grover has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11957616Abstract: Delivery systems and methods for forming and delivering biomaterials from two components are described herein. In particular, apparatus and methods for performing controlled delivery of multicomponent delivery of biomaterials into or onto a body part, such as a body lumen are described. More specifically, in some embodiments, the apparatus and methods are directed towards controlled delivery of micro-volumes of biomaterials into or onto a target location, the micro-volumes being defined as 0.001 mL-1 mL (or 1 ?L-1,000 ?L) of volume.Type: GrantFiled: October 26, 2022Date of Patent: April 16, 2024Assignee: Contraline, Inc.Inventors: Gregory Grover, Kevin S. Eisenfrats
-
Patent number: 11951032Abstract: Delivery systems and methods for forming and delivering biomaterials from two components are described herein. In particular, apparatus and methods for performing controlled delivery of multicomponent delivery of biomaterials into or onto a body part, such as a body lumen are described. More specifically, in some embodiments, the apparatus and methods are directed towards controlled delivery of micro-volumes of biomaterials into or onto a target location, the micro-volumes being defined as 0.001 mL-1 mL (or 1 ?L-1,000 ?L) of volume.Type: GrantFiled: April 26, 2022Date of Patent: April 9, 2024Assignee: Contraline, Inc.Inventors: Gregory Grover, Kevin S. Eisenfrats
-
Patent number: 11933626Abstract: A navigation system includes: a communication unit configured to receive vehicle environment information of a user vehicle, the vehicle environment information including proximate vehicle information representing proximately located vehicles relative to the user vehicle; and a control unit, coupled to the communication unit, configured to: determine lane reference vehicles from the proximately located vehicles based on a vehicle type of the proximately located vehicles; monitor the relative location of the lane reference vehicles; generate a road lane model including a lane delineation estimation based on the relative location of the lane reference vehicles; and calculate a lane position of the user vehicle according to the lane delineation estimation based on a lateral position shift of the user vehicle.Type: GrantFiled: October 26, 2018Date of Patent: March 19, 2024Assignee: Telenav, Inc.Inventors: Alexander G. Glebov, Manuj Shinkar, Kok Wei Koh, Gregory Stewart Aist, HaiPing Jin, Sarvesh Bansilal Devi, Shalu Grover, Jinghai Ren, Yi-Chung Chao
-
Publication number: 20230346589Abstract: Methods for removing a biomaterial implant and reversing occlusive effects of the biomaterial implant are described. In particular, methods for performing removal of biomaterial implants without damage to a body lumen where the biomaterial was previously implanted are presented. More specifically, methods of reversing an implant within a vas deferens using an ablation device are described.Type: ApplicationFiled: May 27, 2021Publication date: November 2, 2023Applicant: Contraline, Inc.Inventors: Gregory GROVER, Kevin EISENFRATS, Tyler CHIARTAS, Robert GREENLEAF
-
Publication number: 20230190515Abstract: Delivery systems, compositions, and methods for forming and delivering biomaterials from two components are described. Specifically, a composition includes a first component and a second component that are each formulated to be crosslinked with the other to form a hydrogel. The first component and the second component are formulated to have an initial storage modulus (initial G) and an initial loss modulus (initial G?) when initially combined such that a ratio of the initial G? to the initial G is between about 5 and about 100. The first component and the second component are formulated to have a gelation storage modulus (gelation G) and a gelation loss modulus (gelation G?) at a gelation time after the first component and the second component are combined such that a atio of the gelation G? to the gelation G is less than about 1. The gelation time is less than about 120 seconds.Type: ApplicationFiled: May 13, 2021Publication date: June 22, 2023Applicant: Contraline, Inc.Inventors: Kevin EISENFRATS, Gregory GROVER, Rucha BHAT, Tyler CHIARTAS, Nicholas MATSUMOTO
-
Publication number: 20230116862Abstract: Delivery systems and methods for forming and delivering biomaterials from two components are described herein. In particular, apparatus and methods for performing controlled delivery of multicomponent delivery of biomaterials into or onto a body part, such as a body lumen are described. More specifically, in some embodiments, the apparatus and methods are directed towards controlled delivery of micro-volumes of biomaterials into or onto a target location, the micro-volumes being defined as 0.001 mL-1 mL (or 1 ?L-1,000 ?L) of volume.Type: ApplicationFiled: October 26, 2022Publication date: April 13, 2023Applicant: Contraline, Inc.Inventors: Gregory GROVER, Kevin S. EISENFRATS
-
Patent number: 11510807Abstract: Delivery systems and methods for forming and delivering biomaterials from two components are described herein. In particular, apparatus and methods for performing controlled delivery of multicomponent delivery of biomaterials into or onto a body part, such as a body lumen are described. More specifically, in some embodiments, the apparatus and methods are directed towards controlled delivery of micro-volumes of biomaterials into or onto a target location, the micro-volumes being defined as 0.001 mL-1 mL (or 1 ?L-1,000 ?L) of volume.Type: GrantFiled: January 25, 2022Date of Patent: November 29, 2022Assignee: Contraline, Inc.Inventors: Gregory Grover, Kevin S. Eisenfrats
-
Publication number: 20220313475Abstract: Delivery systems and methods for forming and delivering biomaterials from two components are described herein. In particular, apparatus and methods for performing controlled delivery of multicomponent delivery of biomaterials into or onto a body part, such as a body lumen are described. More specifically, in some embodiments, the apparatus and methods are directed towards controlled delivery of micro-volumes of biomaterials into or onto a target location, the micro-volumes being defined as 0.001 mL-1 mL (or 1 ?L-1,000 ?L) of volume.Type: ApplicationFiled: April 26, 2022Publication date: October 6, 2022Applicant: Contraline, Inc.Inventors: Gregory GROVER, Kevin S. EISENFRATS
-
Publication number: 20220175672Abstract: Compositions, devices and methods of using one or more hydrogel for contraception as well as localized, sustained delivery of drugs are disclosed. Device (e.g., hydrogel) embodiments are easily injectable, have a quick gelation rate, are highly durable, and are capable of lasting greater than 3 months in vivo. The devices/hydrogel may be used for occlusion of a bodily duct, such as the vas deferens and/or fallopian tubes, for male and female contraception, respectively. Once implanted, the device/hydrogel is able to release one or more drugs, such as small molecules or biologics, indirectly, systemically, and/or directly to the site of interest over a sustained period of time, such as for prevention and/or treatment of STIs.Type: ApplicationFiled: February 22, 2022Publication date: June 9, 2022Inventors: Gregory Grover, Kevin Eisenfrats
-
Publication number: 20220142812Abstract: Delivery systems and methods for forming and delivering biomaterials from two components are described herein. In particular, apparatus and methods for performing controlled delivery of multicomponent delivery of biomaterials into or onto a body part, such as a body lumen are described. More specifically, in some embodiments, the apparatus and methods are directed towards controlled delivery of micro-volumes of biomaterials into or onto a target location, the micro-volumes being defined as 0.001 mL-1 mL (or 1 ?L-1,000 ?L) of volume.Type: ApplicationFiled: January 25, 2022Publication date: May 12, 2022Applicant: Contraline, Inc.Inventors: Gregory GROVER, Kevin S. EISENFRATS
-
Patent number: 11318040Abstract: Delivery systems and methods for forming and delivering biomaterials from two components are described herein. In particular, apparatus and methods for performing controlled delivery of multicomponent delivery of biomaterials into or onto a body part, such as a body lumen are described. More specifically, in some embodiments, the apparatus and methods are directed towards controlled delivery of micro-volumes of biomaterials into or onto a target location, the micro-volumes being defined as 0.001 mL-1 mL (or 1 ?L-1,000 ?L) of volume.Type: GrantFiled: November 12, 2019Date of Patent: May 3, 2022Assignee: Contraline, Inc.Inventors: Gregory Grover, Kevin S. Eisenfrats
-
Patent number: 11253391Abstract: Delivery systems and methods for forming and delivering biomaterials from two components are described herein. In particular, apparatus and methods for performing controlled delivery of multicomponent delivery of biomaterials into or onto a body part, such as a body lumen are described. More specifically, in some embodiments, the apparatus and methods are directed towards controlled delivery of micro-volumes of biomaterials into or onto a target location, the micro-volumes being defined as 0.001 mL-1 mL (or 1 ?L-1,000 ?L) of volume.Type: GrantFiled: November 12, 2019Date of Patent: February 22, 2022Assignee: Contraline, Inc.Inventors: Gregory Grover, Kevin S. Eisenfrats
-
Publication number: 20220015742Abstract: Systems and methods for imaging an object that are capable of capturing an image or images of the object using an imaging modality, automatically detecting and analyzing the image or images by way of converting the image or images to at least one binary image, and analyzing the at least one binary image to extract and/or segment regions-of-interest (ROIs) from the at least one binary image. The object can be or include an implantation, occlusion, medical device, body lumen, tissue, organ, duct, and/or vessel. The imaging modality can be or include X-ray, CT, MRI, PET, and/or ultrasound, or any combination thereof. Also included are compositions of soft, implantable materials with one or more carbon-based material, nanomaterial, and/or allotrope present in an amount sufficient as an ultrasound contrast agent effective for days, months, or years and which compositions are useful in the automated imaging methods of the invention.Type: ApplicationFiled: June 25, 2021Publication date: January 20, 2022Inventors: Gregory Grover, Kevin Eisenfrats, Suchi Patel
-
Publication number: 20210379245Abstract: Compositions and methods for their manufacture and use are provided comprising a soluble extracellular matrix fraction for intravascular delivery which forms a gel or coating in situ for treatment of myocardial infarction and ischemia in a variety of tissues and endothelial injury/dysfunction.Type: ApplicationFiled: October 25, 2019Publication date: December 9, 2021Inventors: Karen Christman, Martin Spang, Gregory Grover
-
Publication number: 20200352649Abstract: Described are methods for reversible occlusion of a body lumen by way of degradation as a result of exposure to one or more stimuli such as light. The methods include administering one or more substance(s) into a body lumen of a subject and forming a stimuli-responsive polymer mass in the body lumen from the one or more substance(s). The mass is sufficient to occlude the body lumen in a manner that prevents transport of at least one material through the body lumen and is susceptible to on-command reversal in the body lumen upon exposure to one or more stimuli. The methods include administering one or more stimuli to a polymer mass in a body lumen for a time and intensity to cause the reverse the polymer mass. The methods are particular useful for applications in which it is desirable to temporarily occlude a body lumen, such as male and female contraception.Type: ApplicationFiled: July 13, 2020Publication date: November 12, 2020Inventors: Kevin Eisenfrats, Gregory Grover, Eric Moran
-
Patent number: 10751124Abstract: Described are methods for reversible occlusion of a body lumen by way of degradation as a result of exposure to one or more stimuli such as light. The methods include administering one or more substance(s) into a body lumen of a subject and forming a stimuli-responsive polymer mass in the body lumen from the one or more substance(s). The mass is sufficient to occlude the body lumen in a manner that prevents transport of at least one material through the body lumen and is susceptible to on-command reversal in the body lumen upon exposure to one or more stimuli. The methods include administering one or more stimuli to a polymer mass in a body lumen for a time and intensity to cause the reverse the polymer mass. The methods are particular useful for applications in which it is desirable to temporarily occlude a body lumen, such as male and female contraception.Type: GrantFiled: January 5, 2018Date of Patent: August 25, 2020Assignee: Contraline, Inc.Inventors: Kevin Eisenfrats, Gregory Grover, Eric Moran
-
Publication number: 20200147301Abstract: Delivery systems and methods for forming and delivering biomaterials from two components are described herein. In particular, apparatus and methods for performing controlled delivery of multicomponent delivery of biomaterials into or onto a body part, such as a body lumen are described. More specifically, in some embodiments, the apparatus and methods are directed towards controlled delivery of micro-volumes of biomaterials into or onto a target location, the micro-volumes being defined as 0.001 mL-1 mL (or 1 ?L-1,000 ?L) of volume.Type: ApplicationFiled: November 12, 2019Publication date: May 14, 2020Applicant: Contraline, Inc.Inventors: Gregory GROVER, Kevin S. EISENFRATS
-
Publication number: 20200146876Abstract: Delivery systems and methods for forming and delivering biomaterials from two components are described herein. In particular, apparatus and methods for performing controlled delivery of multicomponent delivery of biomaterials into or onto a body part, such as a body lumen are described. More specifically, in some embodiments, the apparatus and methods are directed towards controlled delivery of micro-volumes of biomaterials into or onto a target location, the micro-volumes being defined as 0.001 mL-1 mL (or 1 ?L-1,000 ?L) of volume.Type: ApplicationFiled: November 12, 2019Publication date: May 14, 2020Applicant: Contraline, Inc.Inventors: Gregory GROVER, Kevin S. EISENFRATS
-
Patent number: 10611880Abstract: Methods and hydrogels for preventing or reducing cellular adhesion and protein adsorption to a tissue (e.g. cardiac tissue) are disclosed. The hydrogels generally include at least two component polymers, a first polymer including an aminooxy group and a second polymer including a reactive oxo group, that are cross-linked by oxime bonds. The hydrogels are suitable for binding to and coating a tissue or cell. The hydrogels operate to reduce cellular adhesions and protein adsorption to the tissue or cell.Type: GrantFiled: December 9, 2015Date of Patent: April 7, 2020Assignee: The Regents of the University of CaliforniaInventors: Karen Christman, Gregory Grover, Michael Madani, Masaki Fujita
-
Publication number: 20190053790Abstract: Systems and methods for imaging an object that are capable of capturing an image or images of the object using an imaging modality, automatically detecting and analyzing the image or images by way of converting the image or images to at least one binary image, and analyzing the at least one binary image to extract and/or segment regions-of-interest (ROIs) from the at least one binary image. The object can be or include an implantation, occlusion, medical device, body lumen, tissue, organ, duct, and/or vessel. The imaging modality can be or include X-ray, CT, MRI, PET, and/or ultrasound, or any combination thereof. Also included are compositions of soft, implantable materials with one or more carbon-based material, nanomaterial, and/or allotrope present in an amount sufficient as an ultrasound contrast agent effective for days, months, or years and which compositions are useful in the automated imaging methods of the invention.Type: ApplicationFiled: August 17, 2018Publication date: February 21, 2019Inventors: Gregory Grover, Kevin Eisenfrats, Suchi Patel